Use of HEPA Filters Tied to Reduced Systolic BP
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 8, 2025 -- The use of in-home high-efficiency particulate arrestance (HEPA) filters is associated with reductions in systolic blood pressure (SBP) among individuals with elevated SBP, according to a study published online Aug. 6 in the Journal of the American College of Cardiology.
Doug Brugge, Ph.D., from the University of Connecticut Health Center in Farmington, and colleagues examined the efficacy of in-home air purifiers to reduce BP for adults living adjacent to highways in a pragmatic randomized crossover trial. Residences were randomized to start with one month of HEPA or sham filtration, followed by a one-month washout, and one month of the alternate filtration. At the start and end of each filtration period, participant questionnaire data and BP were collected.
A total of 154 participants were included in the analyses. The researchers found that compared with indoor sham and outdoor levels, HEPA filtration significantly reduced particulate matter. The efficacy of the intervention was moderated by participants' SBP at the start of the intervention. A significant 2.8-mm Hg mean decrease in SBP was seen after HEPA filtration compared with a 0.2-mm Hg increase after sham filtration among participants with elevated brachial SBP (≥120 mm Hg). No significant benefit was seen for diastolic BP or among participants with normal SBP.
"High blood pressure remains one of the most important modifiable risk factors for cardiovascular disease," Brugge said in a statement. "This research adds to growing evidence that simple interventions, like in-home air filtration, may help improve heart health for people at risk."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
THURSDAY, Aug. 28, 2025 -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving...
Cocoa Extract Supplementation Does Not Reduce Hypertension Risk
THURSDAY, Aug. 28, 2025 -- Long-term cocoa extract supplementation does not reduce the risk for incident hypertension but does reduce hypertension incidence among those with...
Shared, Sex-Specific Body Fat Patterns Linked to Cardiovascular Aging
WEDNESDAY, Aug. 27, 2025 -- Shared and sex-specific patterns of body fat are associated with changes in cardiovascular aging, according to a study published online Aug. 22 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.